2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow PRM-151: new trials by email Literature Review of PRM-151 trials Research Report on PRM-151
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis PRM-151 (Zinpentraxin Alfa) - Idiopathic Pulmonary Fibrosis | Phase 3 | Terminated | Hoffmann-La Roche | 117 | 2021-08-30 | 2024-05-16 |
| A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis PRM-151 (Zinpentraxin Alfa), Placebo - Idiopathic Pulmonary Fibrosis | Phase 3 | Terminated | Hoffmann-La Roche | 665 | 2021-03-19 | 2024-04-18 |
Idiopathic Pulmonary Fibrosis (2)
Argentina (2) · Australia (2) · Belgium (2) · Canada (2) · China (2) · Czechia (2) · Denmark (2) · France (2) · Germany (2) · Greece (2) · Hong Kong (2) · Hungary (2) · Israel (2) · Italy (2) · Japan (2)